Barclays raises Legence price target to $80
Barclays analyst Adam Seiden maintained an Equal-Weight rating on Legence (NASDAQ: LGN) and raised the price target to $80 from $60.
*this image is generated using AI for illustrative purposes only.
Barclays analyst Adam Seiden has maintained an Equal-Weight rating on Legence (NASDAQ: LGN) while raising the price target to $80 from $60. The adjustment reflects a revised valuation outlook for the company.
Rating and Target Details
The research note confirms the Equal-Weight stance, indicating a neutral performance expectation relative to the broader market. The new price target of $80 represents a significant increase from the previous $60 level.
| Metric | Value |
|---|---|
| Rating | Equal-Weight |
| Previous Price Target | $60 |
| New Price Target | $80 |
What specific factors drove the revised valuation outlook for Legence?
How might Legence's stock perform relative to the broader market given the Equal-Weight rating?
What upcoming catalysts could further influence Legence's stock price?
20
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
